Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Atsuta

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Bone Marrow Transplantation|July 27, 2005
Increased frequency of the angiotensin-converting enzyme gene D-allele is associated with noninfectious pulmonary dysfunction following allogeneic stem cell transplantM Onizuka, M Kasai, T Oba, et al.
Bone Marrow Transplantation|January 26, 2016
Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CRM Mizutani, M Hara, H Fujita, et al.
Leukemia|August 27, 2011
Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia with t(6;9)(p23;q34) dramatically improves the patient prognosis: a matched-pair analysisK Ishiyama, A Takami, Y Kanda, et al.
Bone Marrow Transplantation|May 25, 2004
Allogeneic myeloablative transplantation for patients aged 50 years and overM Yanada, N Emi, T Naoe, et al.
Bone Marrow Transplantation|April 13, 2004
Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host diseaseT Nishida, M Hamaguchi, N Hirabayashi, et al.
Leukemia|January 28, 2005
Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndromeK Nakai, Y Kanda, S Fukuhara, et al.
Leukemia|December 14, 2011
Prognostic factors for acute myeloid leukemia patients with t(6;9)(p23;q34) who underwent an allogeneic hematopoietic stem cell transplantK Ishiyama, A Takami, Y Kanda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2011
A prospective dose-finding trial using a modified continual reassessment method for optimization of fludarabine plus melphalan conditioning for marrow transplantation from unrelated donors in patients with hematopoietic malignanciesS Terakura, Y Atsuta, M Sawa, et al.
Bone Marrow Transplantation|May 24, 2005
Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosisK Shimada, T Yokozawa, Y Atsuta, et al.
Bone Marrow Transplantation|January 24, 2017
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for younger patients with acute myeloid leukemia: a registry-based studyM Yanada, S Kurosawa, T Kobayashi, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Bone Marrow Transplantation|July 27, 2005
Increased frequency of the angiotensin-converting enzyme gene D-allele is associated with noninfectious pulmonary dysfunction following allogeneic stem cell transplantM Onizuka, M Kasai, T Oba, et al.
Bone Marrow Transplantation|January 26, 2016
Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CRM Mizutani, M Hara, H Fujita, et al.
Leukemia|August 27, 2011
Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia with t(6;9)(p23;q34) dramatically improves the patient prognosis: a matched-pair analysisK Ishiyama, A Takami, Y Kanda, et al.
Bone Marrow Transplantation|May 25, 2004
Allogeneic myeloablative transplantation for patients aged 50 years and overM Yanada, N Emi, T Naoe, et al.
Bone Marrow Transplantation|April 13, 2004
Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host diseaseT Nishida, M Hamaguchi, N Hirabayashi, et al.
Leukemia|January 28, 2005
Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndromeK Nakai, Y Kanda, S Fukuhara, et al.
Leukemia|December 14, 2011
Prognostic factors for acute myeloid leukemia patients with t(6;9)(p23;q34) who underwent an allogeneic hematopoietic stem cell transplantK Ishiyama, A Takami, Y Kanda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2011
A prospective dose-finding trial using a modified continual reassessment method for optimization of fludarabine plus melphalan conditioning for marrow transplantation from unrelated donors in patients with hematopoietic malignanciesS Terakura, Y Atsuta, M Sawa, et al.
Bone Marrow Transplantation|May 24, 2005
Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosisK Shimada, T Yokozawa, Y Atsuta, et al.
Bone Marrow Transplantation|January 24, 2017
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for younger patients with acute myeloid leukemia: a registry-based studyM Yanada, S Kurosawa, T Kobayashi, et al.
Pageof 11